MRI volumetric study of dementia with Lewy bodies

Objective: To compare global and regional atrophy on MRI in subjects with dementia with Lewy bodies (DLB), AD, vascular dementia (VaD), and normal aging. In addition, the relationship between APOE-ε4 genotype and volumetric indices was examined. Method: MRI-based volume measurements of the whole-brain, ventricles, frontal lobe, temporal lobe, hippocampus, and amygdala were acquired in elderly subjects with DLB (n = 27; mean age = 75.9 years), AD (n = 25; 77.2 years), VaD (n = 24; 76.9 years), and normal control subjects (n = 26; 76.2 years). Results: Subjects with DLB had significantly larger temporal lobe, hippocampal, and amygdala volumes than those with AD. No significant volumetric difference between subjects with DLB and VaD was observed. Compared with control subjects, ventricular volumes were increased in all patients with dementia, though those with DLB showed a relative preservation of whole-brain volume. There were no significant differences in frontal lobe volumes between the four groups. APOE-ε4 status was not associated with volumetric indices. Conclusion: The findings support the hypothesis that DLB is associated with a relative preservation of temporal lobe structures. In the differentiation of DLB and AD, this may have important implications for diagnosis.

[1]  R. Johnson,et al.  The medial temporal lobe in dementia with lewy bodies: A comparative study with Alzheimer's disease , 1998, Annals of neurology.

[2]  E. Perry,et al.  Neuroleptic sensitivity in patients with senile dementia of Lewy body type. , 1992, BMJ.

[3]  C. Lippa,et al.  Alzheimer's disease and Lewy body disease: A comparative clinicopathological study , 1994, Annals of neurology.

[4]  C. Hofstetter,et al.  Dementia with Lewy Bodies Versus Pure Alzheimer Disease: Differences in Cognition, Neuropathology, Cholinergic Dysfunction, and Synapse Density , 1997, Journal of neuropathology and experimental neurology.

[5]  P. Scheltens,et al.  Apolipoprotein E ϵ4 Allele, Temporal Lobe Atrophy, and White Matter Lesions in Late-Life Dementias , 1999 .

[6]  Jun Kawamata,et al.  Inferior Temporal Lobe Atrophy and APOE Genotypes in Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.

[7]  F. Huppert,et al.  CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia , 1986, British Journal of Psychiatry.

[8]  H. Soininen,et al.  Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes , 1995, Neuroscience.

[9]  H. Soininen,et al.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia , 1996, Neurology.

[10]  H. Duvernoy,et al.  The Human Hippocampus: Functional Anatomy, Vascularization and Serial Sections with MRI , 1997 .

[11]  I G McKeith,et al.  Medial temporal lobe atrophy on MRI in dementia with Lewy bodies , 1999, Neurology.

[12]  I G McKeith,et al.  Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study , 1999, Psychological Medicine.

[13]  C. Jack,et al.  MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.

[14]  C. Jack,et al.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.

[15]  Minoru Yasuda,et al.  Apolipoprotein E ε4 Allele and Whole Brain Atrophy in Late-Onset Alzheimer's Disease , 1998 .

[16]  G. C. Román,et al.  Vascular dementia , 1993, Neurology.

[17]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging , 1999, Journal of neurology, neurosurgery, and psychiatry.

[18]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[19]  R. Levy,et al.  The Lewy-Body Variant of Alzheimer's Disease , 1993, British Journal of Psychiatry.

[20]  J. O'brien.  Is hippocampal atrophy on magnetic resonance imaging a marker for Alzheimer's disease? , 1995 .

[21]  D. Dickson,et al.  Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway , 1997, Journal of the Neurological Sciences.

[22]  E. Mori,et al.  Medial temporal and whole-brain atrophy in dementia with Lewy bodies , 1998, Neurology.

[23]  D. Dickson,et al.  Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease , 1991, Neurology.

[24]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[25]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[26]  K. Double,et al.  Regional brain atrophy in idiopathic parkinson's disease and diffuse Lewy body disease. , 1996, Dementia.

[27]  G A Johnson,et al.  In vitro MR microscopy of the hippocampus in Alzheimer's disease , 1993, Neurology.

[28]  H. Soininen,et al.  Major decrease in the volume of the entorhinal cortex in patients with Alzheimer’s disease carrying the apolipoprotein E ε4 allele , 1998, Journal of neurology, neurosurgery, and psychiatry.

[29]  C. Coffey,et al.  Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. , 1993, Archives of general psychiatry.

[30]  P. Ince,et al.  Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients , 1991, Journal of the Neurological Sciences.

[31]  E. Perry,et al.  Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. , 1999, The American journal of psychiatry.

[32]  E G Tangalos,et al.  Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease , 1998, Annals of neurology.

[33]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[34]  H. Soininen,et al.  SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[35]  J. Wegiel,et al.  Neurofibrillary pathology — correlation with hippocampal formation atrophy in Alzheimer disease , 1996, Neurobiology of Aging.